
Mangoceuticals, Inc.
MGRXNasdaqCIK 1938046HealthcareFiscal year ends Dec 31
Reports and events: 118 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-02-1917:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-007597 |
| 2025-02-1809:00 ET | DEF 14A | Proxy statementPeriod 2025-02-18 | 0001493152-25-007103 |
| 2025-02-1216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-006139 |
| 2025-02-1208:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-006040 |
| 2025-02-0717:25 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-005457 |
| 2025-01-3117:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-004501 |
| 2025-01-2116:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-003054 |
| 2025-01-1516:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-002389 |
| 2025-01-0816:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-001401 |
| 2024-12-2616:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-052111 |
| 2024-12-1917:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050830 |
| 2024-12-0617:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-049133 |
| 2024-11-1416:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045895 |
| 2024-11-1217:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-044828 |
| 2024-10-3108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-043134 |
| 2024-10-2517:00 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-24-042546 |
| 2024-10-2208:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-041885 |
| 2024-10-2117:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041802 |
| 2024-10-1117:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040955 |
| 2024-10-0308:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039300 |
| 2024-10-0217:25 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-24-039223 |
| 2024-10-0107:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-038933 |
| 2024-09-2716:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-24-038544 |
| 2024-08-2719:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-034062 |
| 2024-08-2316:41 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001493152-24-033739 |
| 2024-08-1616:44 ET | S-1 | Registration statement | 0001493152-24-032841 |
| 2024-08-1509:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032517 |
| 2024-08-1417:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032410 |
| 2024-07-1108:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-026887 |
| 2024-07-0216:40 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-026029 |
| 2024-06-1818:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-024199 |
| 2024-06-0517:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001493152-24-022808 |
| 2024-06-0517:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-022809 |
| 2024-05-1609:19 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0001493152-24-020141 |
| 2024-05-1516:52 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019960 |
| 2024-05-0617:32 ET | S-1/A | Registration statement, amended | 0001493152-24-017953 |
| 2024-05-0208:00 ET | 8-K | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017488 |
| 2024-04-2508:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015859 |
| 2024-04-2317:28 ET | S-1 | Registration statement | 0001493152-24-015724 |
| 2024-04-1116:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014330 |
| 2024-04-0117:21 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-012508 |
| 2024-03-2617:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-011360 |
| 2024-03-0109:00 ET | DEF 14A | Proxy statementPeriod 2024-03-01 | 0001493152-24-008415 |
| 2024-01-2517:16 ET | 8-K | 8.01 Other events | 0001493152-24-003785 |
| 2024-01-2319:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-003338 |
| 2024-01-0221:51 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-23-046642 |
| 2024-01-0221:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-046641 |
| 2023-12-1916:32 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-045420 |
| 2023-12-1217:14 ET | S-1/A | Registration statement, amended | 0001493152-23-044594 |
| 2023-12-1117:29 ET | S-1 | Registration statement | 0001493152-23-044447 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:08 ET. Listed shows no prices and gives no investment advice.